NMRA - Neumora Therapeutics PEG multiplikatori
Neumora Therapeutics (NMRA) markaziy nerv tizimi buzilishlari uchun dori vositalarini aniq tanlash maqsadida AI platformalarini joriy qilmoqda, bu esa o'rtacha PEG ko'rsatkichi bilan tasdiqlanadi. Joriy raqam 0.00 darajasida turibdi. Biznesning rivojlanishi tartibga soluvchi organlarning ruxsatnomalari va biomarkerlar aniqligiga bog'liq. Kompaniya hozirda molekulalarni tezlashtirilgan skrining qilish uchun avtomatlashtirilgan manipulatorlardan foydalanib, robot texnikalari majmualarini kengaytirmoqda.
neumoratx.com (NMRA) kompaniyasining tahliliy kesimlari
- joriy kotirovkalar va o'rtacha qiymat prognozi:
- bozor kapitallashuvi statistikasi:
- balans bo'yicha xususiy kapital ma'lumotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Barcha qarzlarning o‘z mablag‘lariga nisbati Neumora Therapeutics|NMRA - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati Neumora Therapeutics Inc|NMRA - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Neumora Therapeutics, Inc.|NMRA - Kompaniyaning uzoq muddatli majburiyatlari|Qisqa muddatli majburiyatlar miqdori Neumora Therapeutics|Oraliq qoplash koeffitsiyenti neumoratx.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
NMRA - Sof foyda|Kutilayotgan sof foyda Neumora Therapeutics|NMRA - Narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori Neumora Therapeutics|NMRA - PEG multiplikatori|EV/EBITDA multiplikatori Neumora Therapeutics|NMRA - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi 12 oy davomida bitta aksiya uchun foyda Neumora Therapeutics|NMRA - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi neumoratx.com|NMRA - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Neumora Therapeutics
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning jamlanma tahliliyoti:Neumora Therapeutics, NMRA
Istiqbolli emitentlarni tanlash bozor qiymatini foyda o'sishi bilan solishtirishga asoslangan bo'lib, bunda birdan past qiymat aktivning qadrsizlanganini anglatadi. PEG koeffitsiyentini tahlil qilish orqali investor Neumora Therapeutics (NMRA) ilmiy xodimlariga kiritilgan investitsiyalar samaradorligini baholaydi, ularning neyrofan rivojlanishlari va klinik sinovlari ushbu grafikda aks etgan kelajakdagi kapitalizatsiya potentsialini belgilaydi.
Neumora Therapeutics kimlar bilan raqobatlashadi
O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Biogen Idec|Neurocrine Corp - Narx-foyda va o‘sish multiplikatori|regencellbioscience.com (RGC) - O‘sish sur’atiga tuzatilgan narx-foyda|AXSM - Narxning foydaga va o‘sish sur’atiga nisbati|ACAD (ACADIA Pharmaceuticals Inc.) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Xenon Pharmaceuticals (XENE) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti VKTX|Narxning foydaga va o‘sish sur’atiga nisbati Supernus|O‘sish sur’atiga tuzatilgan narx-foyda catalystpharma.com CPRX|Narx-foyda va o‘sish multiplikatori DNLI (Denali Therapeutics Inc.)|HRMY - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Biohaven Ltd. BHVN|AMLX (Amylyx) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Trevi Therapeutics Inc - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti PRAX (Praxis Precision Medicines)|AVXL: PEG multiplikatori|CBLL - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati prothena.com|Narx-foyda va o‘sish multiplikatori Alector (ALEC)|Narx-foyda va o‘sish multiplikatori ANNX (annexonbio.com)|OMER - O‘sish sur’atiga tuzatilgan narx-foyda|PEG multiplikatori NGNE (Neurogene Inc)|PEG multiplikatori AC Immune S.A. ACIU|VYGR - Narxning foydaga va o‘sish sur’atiga nisbati|Narxning sof foyda o‘sishiga nisbati Scilex Holding Company (SCLX)|Tevogen Bio Holdings (TVGN) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti ACOG|Narxning foydaga va o‘sish sur’atiga nisbati Cognition Therapeutics, Inc.|Inhibikase Therapeutics, Inc. - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori SAVA (Cassava)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Assertio Therapeutics|Coya Therapeutics, Inc. - Narx-foyda va o‘sish multiplikatori|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati VTGN (VistaGen Therapeutics Inc)|Ovid Therapeutics Inc - PEG multiplikatori|Acumen Pharmaceuticals, Inc. (ABOS) - Narx-foyda va o‘sish multiplikatori|CRVO (CervoMed, Inc.) - Narx-foyda va o‘sish multiplikatori|Narx-foyda va o‘sish multiplikatori Alterity Therapeutics Ltd|Narxning foydaga va o‘sish sur’atiga nisbati Clene Inc.|PepGen Inc. - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori JUNS (Jupiter Neurosciences Inc)|Narxning foydaga va o‘sish sur’atiga nisbati RLMD (Relmada Therapeutics Inc)|Annovis Bio Inc - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Grace Tx (GRCE)|fireflyneuro.com - PEG multiplikatori|Klotho Neurosciences (KLTO) - Narx-foyda va o‘sish multiplikatori|NeuroSense Therapeutics, Ltd. (NRSN) - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati RVPH (Reviva Pharmaceuticals Holdings, Inc.)|MTVA (MetaVia) - PEG multiplikatori|NRXS: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori HSDT|PEG multiplikatori Passage Bio Inc. (PASG)|Narxning foydaga va o‘sish sur’atiga nisbati bionomics.com.au NEUP|PEG multiplikatori Minerva Neurosciences Inc NERV|ATHA: Narx-foyda va o‘sish multiplikatori|ADXN (Addex Therapeutics, Ltd.) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Alzamend Neuro Inc. (ALZN) - Narxning foydaga va o‘sish sur’atiga nisbati|Cyclerion - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati protagenic.com|Pasithea Therapeutics - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori CRGT (Cortigent, Inc.)|Avenue Therapeutics - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Brainstorm Cell BCLI|PEG multiplikatori caratherapeutics.com CARA|Chromocell Therapeutics Corp. - PEG multiplikatori|eliemtx.com - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|Intra-Cellular Therapies (ITCI) - Narxning foydaga va o‘sish sur’atiga nisbati|LBPH (Longboard) - Narxning foydaga va o‘sish sur’atiga nisbati|MRNS (marinuspharma.com) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda NKGen Biotech NKGN|Narxning foydaga va o‘sish sur’atiga nisbati NeuroBo Pharma (NRBO)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati SAGE|Synaptogenix, Inc. - Narx-foyda va o‘sish multiplikatori|TRVN: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|VIGL - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti WENA (Anew Medical, Inc.)|CERE: PEG multiplikatori
